^
Phase 2
Novartis Pharmaceuticals
Completed
Last update posted :
02/11/2025
Initiation :
04/06/2018
Primary completion :
11/14/2022
Completion :
11/14/2022
FLT3 • PML
|
FLT3 mutation
|
cytarabine • midostaurin • daunorubicin
Phase 2
Institute of Hematology & Blood Diseases Hospit...
Recruiting
Last update posted :
12/30/2024
Initiation :
03/02/2023
Primary completion :
12/30/2026
Completion :
03/02/2027
IFNG • IL6 • TNFA • IL10 • IFNA1
|
azacitidine • prednisone • Epidaza (chidamide) • Duoenda (mitoxantrone liposomal)
Phase N/A
Peking University People's Hospital
Recruiting
Last update posted :
05/10/2024
Initiation :
01/01/2023
Primary completion :
12/31/2024
Completion :
12/31/2024
RARA • PML
|
etoposide IV • daunorubicin
Phase 2
Vanderbilt-Ingram Cancer Center
Active, not recruiting
Last update posted :
05/03/2024
Initiation :
03/01/2016
Primary completion :
04/01/2019
Completion :
09/01/2024
SRC
|
cytarabine • Qinprezo (vosaroxin) • Starasid (cytarabine ocfosfate)
Phase 3
Technische Universität Dresden
Completed
Last update posted :
09/15/2023
Initiation :
04/16/2014
Primary completion :
04/25/2022
Completion :
04/25/2022
NPPB
|
daunorubicin
Phase 2
National Cancer Institute (NCI)
Completed
Last update posted :
03/01/2023
Initiation :
12/14/2010
Primary completion :
07/01/2013
Completion :
03/15/2021
RUNX1 • RUNX1T1
|
RUNX1-RUNX1T1 fusion • CBFB-MYH11 fusion
|
dasatinib • cytarabine • daunorubicin • Starasid (cytarabine ocfosfate)
Phase 1
Tara Lin
Completed
Last update posted :
01/14/2022
Initiation :
11/01/2016
Primary completion :
04/03/2019
Completion :
07/15/2021
CTNNB1
|
daunorubicin
Phase 4
Xiaofan Zhu
Completed
Last update posted :
08/10/2021
Initiation :
05/01/2010
Primary completion :
02/01/2017
Completion :
02/01/2017
RARA
|
cytarabine • daunorubicin • arsenic trioxide
Phase 2
National Cancer Institute (NCI)
Active, not recruiting
Last update posted :
06/21/2021
Initiation :
09/16/2011
Primary completion :
02/11/2016
RARA • CBFB
|
cytarabine • azacitidine • decitabine • daunorubicin • Starasid (cytarabine ocfosfate)
Phase 3
Eastern Cooperative Oncology Group
Recruiting
Last update posted :
12/08/2017
Initiation :
01/01/2011
Primary completion :
02/01/2019
HLA-DRB1
|
cytarabine • decitabine • daunorubicin • clofarabine
Phase 2
Sunesis Pharmaceuticals
Completed
Last update posted :
07/27/2017
Initiation :
12/20/2006
Primary completion :
06/09/2010
Completion :
06/09/2010
MUC16
|
cisplatin • Qinprezo (vosaroxin)
Phase N/A
Nanfang Hospital of Southern Medical University
Unknown status
Last update posted :
04/21/2015
Initiation :
08/01/2013
Primary completion :
07/01/2016
Completion :
07/01/2016
ABCB1 • WT1 • GAPDH
|
ABCB1 overexpression
|
cytarabine • daunorubicin • idarubicin hydrochloride